COPD is one of the most common chronic conditions among Medicare beneficiaries. Inhaler costs, home oxygen coverage, and pulmonary rehab are the key factors to evaluate in any plan.
Educational content only. This page is not medical advice. Consult your physician for medical guidance and a licensed insurance professional for coverage decisions.
Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases — primarily emphysema and chronic bronchitis — that cause airflow obstruction and breathing difficulty. The airways become inflamed and narrowed, and the lung tissue loses its elasticity, making it increasingly hard to breathe.
COPD affects approximately 16 million Americans and is the fourth leading cause of death in the U.S. It is most commonly caused by long-term exposure to cigarette smoke, though air pollution and occupational dust exposure are also significant factors.
COPD is progressive and incurable, but its progression can be significantly slowed with treatment. Quitting smoking is the single most effective intervention. Many people with COPD live for decades after diagnosis with good symptom management.
Respiratory infections can trigger dangerous COPD exacerbations. Medicare covers annual flu vaccines, pneumococcal vaccines, and COVID-19 vaccines at no cost. Confirm your plan covers these preventive vaccines — all Medicare plans are required to cover them with no cost-sharing.
Inhaler costs and respiratory equipment coverage are the top priorities for most COPD patients evaluating plans.
Brand-name inhalers can be expensive on high-tier formularies. Use the Medicare Plan Finder to check your specific medications — or work with an agent who can compare plans for you.